Skip to main content
. 2017 Jul 15;8(7):381–389. doi: 10.4239/wjd.v8.i7.381

Table 7.

Insulin dose (U/d) before and after autologous bone marrow derived stem cell therapy in Group I

Patient Baseline 3 mo 6 mo 12 mo 18 mo 24 mo
1 32 22 16 Nil Nil Nil
2 66 55 53 53 50 _
3 30 20 16 14 - -
4 46 26 20 20 - -
5 40 18 12 - - -
6 48 8 10 - - -
7 Lost to FU
Mean ± SE 44 ± 5 25 ± 7 21 ± 7
P value 0.011 0.003